Publication at Third Faculty of Medicine |
2006
Abstract
In recent years, the cannabinoid system has become an increasingly grateful object of interest in a wide range of medical disciplines. It is very often discussed in connection with the treatment of Parkinson's disease or Alzheimer's dementia, cannabinoid receptor antagonists are tested in the treatment of vomiting (dronabinol, nabinol) or obesity (rimonabant), etc., and relatively recently we have a unique opportunity to encounter cannabinoids level) in the position of analgesic.